Amn Healthcare Services INC 8-K filings

AMN Healthcare reported strong first quarter 2026 financial results, with revenue and adjusted EBITDA surpassing guidance due to robust performance in key staffing segments.

AMN Healthcare Services, Inc. announced that its shareholders approved an amendment to the 2025 Equity Plan, increasing the number of authorized shares and ratifying the appointment of KPMG LLP.

AMN Healthcare Services, Inc. announced the retirement of R. Jeffrey Harris from its Board of Directors and the intent to nominate Eric Palmer as his successor.

AMN Healthcare Services, Inc. presented its strategic vision and financial outlook at the J.P. Morgan Healthcare Conference, highlighting a return to growth in key segments and leveraging technology to address healthcare labor shortages.

AMN Healthcare Services, Inc. adopted amended and restated by-laws to enhance corporate governance, streamline shareholder meeting procedures, and refine director nomination processes.

AMN Healthcare reported third quarter 2025 financial results exceeding guidance, driven by strong staffing order rebound and strategic debt refinancing.

AMN Healthcare Services, Inc. announced a $400 million senior notes offering and an amendment to its credit agreement, extending maturity and refinancing existing debt.

AMN Healthcare announced a private offering of $400 million in senior unsecured notes due 2031 to refinance its existing $500 million notes due 2027.

AMN Healthcare Services, Inc. announced plans to amend its existing credit agreement, extending the maturity to October 2030 and reducing the facility size to $450 million.

AMN Healthcare reported a significant net loss in Q2 2025 due to goodwill and intangible asset impairment charges, despite revenue being near guidance and strong cash flow.

AMN Healthcare reported Q1 2025 revenue of $690 million, exceeding guidance, but experienced a net loss of ($0.03) per share and a decrease in adjusted EPS to $0.45.

AMN Healthcare Services, Inc. shareholders approved the AMN Healthcare 2025 Equity Plan at the Annual Meeting of Shareholders held on May 2, 2025.

AMN Healthcare's Q4 2024 results show a revenue decrease of 10% year-over-year, with a net loss driven by a significant goodwill impairment charge.

Douglas D. Wheat retires as Chairman of AMN Healthcare Services, effective immediately, with Mark G. Foletta appointed as the new Chairman.

AMN Healthcare Services, Inc. announces the retirement of its Chairman, Douglas D. Wheat, and the appointment of Mark G. Foletta as his successor, effective after the 2025 annual meeting.

AMN Healthcare exceeded expectations in the third quarter of 2024, reporting revenue of $688 million and adjusted EPS of $0.61, despite a challenging market environment.

AMN Healthcare has appointed Brian Scott as its new Chief Financial Officer and Chief Operating Officer, effective November 21, 2024, marking his return to the company after previously serving as CFO from 2011 to 2021.

AMN Healthcare announced the departure of its CFO, Jeffrey Knudson, effective November 8, 2024, while reaffirming its financial guidance for the third quarter of 2024.

AMN Healthcare's second quarter revenue declined by 25% year-over-year to $741 million, but earnings exceeded expectations due to expense management and discrete items.

AMN Healthcare Services, Inc. has increased its board size and appointed James H. Hinton as a new independent director, effective July 22, 2024.

AMN Healthcare's first quarter results show a significant revenue decrease year-over-year, though earnings were better than expected due to proactive expense management.

AMN Healthcare Services held its annual shareholder meeting on April 19, 2024, where directors were elected and proposals regarding executive compensation, auditor ratification, and corporate charter amendments were approved.

Martha H. Marsh, a long-serving member of AMN Healthcare's board of directors, will not seek re-election at the company's 2024 annual meeting.

AMN Healthcare announced its fourth quarter and full year 2023 results, highlighting a significant revenue decrease due to a cyclical industry reset, while also emphasizing investments in technology and strategic acquisitions.